Corrigendum to: “An Overview of Conventional Drugs and Nanotherapeutic Options for the Treatment and Management of Pediatric Acute Lymphoblastic Leukemia” | Bentham Science Publishers

2000

Volume 25, Issue 11

ISSN: 1871-5206
E-ISSN: 1875-5992

Corrigendum to: “An Overview of Conventional Drugs and Nanotherapeutic Options for the Treatment and Management of Pediatric Acute Lymphoblastic Leukemia”
Authors: Andre Yonan¹, Christopher Jacques¹, Tafaswa Fletcher¹, Thanaphorn Suk-in¹ and Robert B. Campbell¹
View Affiliations Hide Affiliations

¹ Department of Pharmaceutical Sciences, School of Pharmacy, MCPHS University, 19 Foster Street, Worcester, MA 01608, USA
Source: Anti-Cancer Agents in Medicinal Chemistry, Volume 25, Issue 11, Jul 2025, p. 811 - 811
DOI: https://doi.org/10.2174/1871520625999250213162929
- Available online: 13 Feb 2025

There is no abstract available.

© 2025 Bentham Science Publishers

Article metrics loading...

/content/journals/acamc/10.2174/1871520625999250213162929

2025-02-13

2025-11-06

From This Site

/content/journals/acamc/10.2174/1871520625999250213162929

dcterms_title,dcterms_subject,pub_keyword

-contentType:Contributor -contentType:Concept -contentType:Institution

10

5

Loading full text...

Full text loading...

References

YonanA. JacquesC. FletcherT. Suk-InT. CampbellR.B. An overview of conventional drugs and nanotherapeutic options for the treatment and management of pediatric acute lymphoblastic leukemia.Anticancer. Agents Med. Chem.2022221830503061
[Google Scholar]

/content/journals/acamc/10.2174/1871520625999250213162929

Article Type: Correction

Most Cited Most Cited RSS feed

This is a required field

Please enter a valid email address

Approval was a Success

Invalid data

An Error Occurred

Approval was partially successful, following selected items could not be processed due to error

Please enter a valid_number test